USANA Health Sciences, Inc. (USNA) — Financial statements
Income statement, balance sheet, and cash flow for USANA Health Sciences, Inc. — annual and quarterly history with growth and margin analysis.
| Metric (USD Millions) | 2026 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
| Revenue & Gross Profit | ||||||
| Revenue | 925↑8.3% | 855↓7.2% | 921↓7.8% | 999↓15.8% | 1,186 | |
| Cost of Revenue | 201↑14.3% | 176↓7.2% | 189↓8.6% | 207↓10.2% | 231 | |
| Gross Profit | 724↑6.7% | 679↓7.2% | 732↓7.5% | 791↓17.2% | 956 | |
| Operating Expenses | ||||||
| R&D Expenses | 0.00↓100.0% | 12↑1.1% | 11↓1.0% | 12↑4.1% | 11 | |
| General & Administrative Expenses | 337 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Selling & Marketing Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| SG&A Expenses | 337↓43.9% | 601↓4.2% | 627↓6.7% | 672↓13.2% | 774 | |
| Other Expenses | 336 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Operating Expenses | 674↑10.0% | 612↓4.1% | 639↓6.6% | 684↓12.9% | 785 | |
| Total Costs & Expenses | 874↑10.9% | 788↓4.8% | 828↓7.1% | 891↓12.3% | 1,016 | |
| Operating Results | ||||||
| Operating Income | 51↓23.3% | 66↓28.7% | 93↓13.5% | 108↓36.8% | 170 | |
| Depreciation & Amortization | 40↑78.6% | 22↑9.0% | 20↓4.7% | 21↓3.5% | 22 | |
| EBITDA | 82↓17.0% | 99↓19.7% | 123↓5.5% | 130↓32.5% | 193 | |
| EBIT | 42↓44.7% | 77↓25.4% | 103↓5.6% | 109↓36.3% | 171 | |
| Interest & Other Income | ||||||
| Net Interest Income | 2↓85.7% | 11↑17.7% | 9↑160.6% | 4↑46.3% | 2 | |
| Interest Income | 2↓78.7% | 11↑17.5% | 10↑154.3% | 4↑50.7% | 3 | |
| Interest Expense | 0.84↑199.6% | 0.28↑7.3% | 0.26↑36.5% | 0.19↑236.8% | 0.06 | |
| Non-Operating Income | 8↑182.4% | -10↓6.9% | -10↓704.3% | -1↓136.5% | -0.51 | |
| Other Income / Expenses | -9↓193.1% | 10↑6.9% | 9↑831.7% | 1↑123.8% | 0.45 | |
| Income Before Tax | 42↓45.6% | 76↓25.5% | 102↓5.7% | 109↓36.3% | 171 | |
| Income Tax Expense | 30↓12.4% | 34↓11.3% | 39↓1.5% | 39↓27.5% | 54 | |
| Net Income & EPS | ||||||
| Net Income from Continuing Operations | 11↓72.7% | 42↓34.1% | 64↓8.0% | 69↓40.5% | 117 | |
| Net Income from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Net Income | 11↓74.4% | 42↓34.1% | 64↓8.0% | 69↓40.5% | 117 | |
| Bottom-Line Net Income | 11↓74.4% | 42↓34.1% | 64↓8.0% | 69↓40.5% | 117 | |
| EPS (Basic) | 0.58↓73.6% | 2.20↓33.9% | 3.33↓7.5% | 3.60↓37.7% | 5.78 | |
| EPS (Diluted) | 0.58↓73.5% | 2.19↓33.6% | 3.30↓8.1% | 3.59↓37.3% | 5.73 | |
| Weighted Average Shares | 19↓2.6% | 19↓1.0% | 19↓0.0% | 19↓4.4% | 20 | |
| Weighted Average Diluted Shares | 19↓3.1% | 19↓0.9% | 19↑0.2% | 19↓5.1% | 20 | |
* All figures in Millions of USD, except per share data. Growth rates calculated Year-over-Year (YoY). Data source: SEC Filings.